Abstract

A method of pain control is provided by the intrapulmonary delivery of a pharmaceutically active pain relief formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring and separately determining inspiratory flow rate and inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release in response to a separately measured inspiratory rate and inspiratory volume. To obtain repeatability in dosing the narcotic formulation is repeatedly released at the same measured (1) inspiratory flow rate and (2) inspiratory volume. To maximize the efficiency of the delivery the narcotic formulation is released at (1) a measured inspiratory flow rate in the range of from about 0.10 to about 2.0 liters/second and (2) a measured inspiratory volume in the range of about 0.15 to about 0.8 liters. Abuse of narcotic formulations is avoided by providing a tamper-resistant device which includes a variety of security features including a pre-programmed microprocessor designed to avoid overdosing.

Other References

• Camp, J.P., "Patient-Controlled Analgesia", 1991, AFP Clinical Pharmacology, 44:2145-2150
• Chrusbasik, H. et al., "Absorption and bioavailability of nebulized morphine", 1988, Br. F. Anaesth. 61:228-230
• Gourlay, G.K., "Fentanyl Blood Concentration-Analgesic Response Relationship in the Treatment of Postoperative Pain", 1988, Anesth. Analg. 67:329-337
• Jaffe, A.B. et al., 1989, "Rats self-administer sufentanil in aerosol form", Psychopharmacology, 99:289-293
• Lehman, K.A. et al., 1991, "Transdermal fentanyl for the tretment of pain after major urological operations", Eur. J. Clin. Pharmacol. 41:17-21
• Mather, L.E., "Pharmacokinetics and patient-controlled analgesia(*)", 1992, Acta Anaesthesiologica Belgica, 43:5-20
• Miller, R., "Anesthesia Second Edition", 1986, Churchill Livingstone, 1:762
• Newman, S.P. et al., "Deposition of pressurized aerosols in the human respiratory tract", 1981, Thorax, 36:52-55
• Newman, S.P. et al., "How should a pressurized ଲ-adrenergic bronchodilator be inhaled?", 1981, Eur. J. Respir. Dis. 62:3-21
• Newman, S.P. et al., "Deposition of pressurized suspension aerosols inhaled through extension devices", 1981, Am. Rev. Respir. Dis. 124:317-320
• Newman, S.P., "Deposition and Effects of Inhalation Aerosols", 1983, Dept. of Thoracic Medicine
• Rapp, R.P. et al., "Patient-controlled analgesia:a review of effectiveness of therapy and an evaluation of currently available devices", 1989, DICP, The Annals of Pharmacotherapy 23:899-904
• Rosenberg, M., "Patient-Controlled Analgesia", 1992, J. Oral Maxillofac. Surg. 50:386-389
• Rowbotham, D.J., "A disposble device for patient-controlled analgesia with fentanyl", 1989, Anaesthesia, 44:922-924
• Ryder, E., "The history of patient-controlled analgesia", 1991, Journal of Intravenous Nursing, 14(6):372-281
• Shade, P., "Patient-controlled analgesia: can client education improve outcomes?", 1992, Journal of Advanced Nursing, 17:408-413
• Smythe, M., "Patient-controlled analgesia: a review", 1992, Pharmacotherapy, 99:289-293
• Stanley, T.H., "The history and development of the fentanyl series", 1992, Journal of Pain and Symptom Management, 7(Suppl.):S3-7
• Worsley, M.H. et al., "Inhaled fentanyl as a method of analgesia", Anaesthesia, 45:449-451
• "How Should A Pressurized B-adrenergic Bronchodilator be Inhaled?" by Neman et al., Eur. J. Respir. Dis. (1991) 62, 3-2